Schedule 13G ownership disclosure

Can-Fite BioPharma Ltd.

Security class unavailable · CUSIP: 13471N201

Event date: 2019-05-20

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
9,757,860
Percent of class
9.7900%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001535610-19-000087
Form type
SC 13G
Filer
Can-Fite BioPharma Ltd.
CIK
CIK 1536196
Filed
May 22, 2019
Reporting period
May 20, 2019
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub